Novocure to Report Second Quarter 2024 Financial Results

ROOT, Switzerland–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial marke

NovocureJul 1 12:00

Stocks With the Highest and Lowest Liquidity - Goldman Sachs

Seeking AlphaJun 10 04:23

10 Health Care Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaJun 8 01:35

Novocure(NVCR.US) Director Sells US$23,027.45 in Common Stock

$Novocure(NVCR.US)$ Director Scannell Timothy J sold 964 shares of common stock on Jun 4, 2024 at an average price of $23.8874 for a total value of $23,027.45.Source: Announcement What is statement of

Futu NewsJun 7 06:25

A Closer Look at 7 Analyst Recommendations For NovoCure

7 analysts have shared their evaluations of NovoCure (NASDAQ:NVCR) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings,

BenzingaJun 4 21:01

Novocure Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Novocure Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Dow JonesJun 4 18:20